The expanded approval is for the adjuvant treatment of advanced melanoma after complete resection in

In the absence of legislation requiring access to menstruation products in schools, students are campaigning

Cost of therapy and the need for repeated injections are barriers to omalizumab’s adjunctive role.

Lab turnaround time followed by the cost of biomarker testing and adequate insurance coverage were

Among adults with out-of-hospital cardiac arrest, giving calcium did not improve return of spontaneous circulation,

Major life events, such as getting married, having a baby, or retiring from work, can

The cancer organization today largely reinstated its former advice that men with low-risk prostate cancer

An abundance of mutations make the new variant very unpredictable, but booster shots may still

For patients with metastatic melanoma, triplet therapy with atezolizumab and vemurafenib plus cobimetinib provides significant

New data on adults reflect the link between social media and depression seen in youths.